TransMedics (TMDX) Director Edwin Kania Receives RSU Award

What Happened

• Edwin Kania, a director of TransMedics Group, was granted 2,922 restricted stock units (RSUs) on 2026-05-20. The Form 4 reports an acquisition with a reported price of $0 (this is a compensatory grant, not a market purchase or sale).

Key Details

• Transaction date: 2026-05-20; Filing date: 2026-05-22 (filed two days after the transaction; appears timely under the two-business-day Form 4 rule).
• Transaction type/code: Award/Grant (A).
• Shares/units granted: 2,922 RSUs; reported acquisition price: $0.
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Footnote: The grant consists of 2,922 RSUs. Each RSU is a contingent right to receive one share of common stock upon vesting (footnote F1).
• No indication of a 10b5-1 plan, tax-withholding sale, or exercise/sale pattern in this filing excerpt.

Context

• RSUs are compensation that convert to actual shares only when they vest; they are not an immediate market purchase and do not necessarily signal insider buying or selling intent. Such awards are routine for directors and executives and are often part of a compensation package.